Structure Therapeutics Inc.
GPCR
$56.65
$2.905.40%
NASDAQ
| 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | |
|---|---|---|---|---|---|
| Net Income | 150.23% | -6.57% | -31.66% | -28.38% | -7.36% |
| Total Depreciation and Amortization | 93.67% | 30.24% | 6.20% | 3.01% | -3.62% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | -189.55% | 29.39% | 229.13% | 304.64% | -7.28% |
| Change in Net Operating Assets | -1,086.47% | 208.53% | 145.32% | -1,173.97% | -103.90% |
| Cash from Operations | -26.32% | 6.53% | -4.46% | -43.22% | -85.15% |
| Capital Expenditure | 4.83% | -577.59% | 26.11% | -1,862.50% | 97.66% |
| Sale of Property, Plant, and Equipment | -1.30% | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | 199.32% | -207.59% | 43.17% | 3.31% | 117.65% |
| Cash from Investing | 213.83% | -200.77% | 43.81% | 2.41% | 117.58% |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | 1,129.63% | 11,009.28% | -46.42% | 56.91% | 54.91% |
| Repurchase of Common Stock | 100.00% | -- | 100.00% | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -62.34% | -- | -- | -- | 100.00% |
| Cash from Financing | 1,154.36% | 10,770.99% | -36.09% | 31.54% | 181.24% |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 1,679.41% | -765.11% | 70.67% | -563.63% | 98.75% |